Arrays for cell Nanodevices S.L (A4Cell), has closed an investment round of . 1,250,000 in which its current partners, Innvierte Economía Sostenible Sicc Sme SA and BeAble Innvierte Kets Fund managed by the company Beable Capital SGEIC, have participated, with the addition of a new investment partner, Ideas de Bomberos SL, a company led by Alfonso Francisco Hidalgo Enguix, a private investor with extensive experience in the sector, having been co-founder of the biotechnology company Infinitec Activos.
A4Cell began its journey in 2018 thanks to BeAble Capital, a fund management company specialized in Science Equity that invests in disruptive technologies emerging in universities and research centers at very early stages. BeAble Capital identified the enormous potential of the innovative technology developed by A4Cell creating, with the support of researchers at the Institute of Microelectronics of Barcelona, this Spin Off that now makes the final leap to the national and international market.
The capital injection recently provided by Alfonso Francisco Hidalgo Enguix is great news for the company, as its CEO, Elena Rivas, comments: "We are very proud of this new milestone, thanks to which A4Cell begins a stage with exciting challenges in which we are sure we will reap important successes, offering a paradigm shift in the analysis of live cells, thus providing the pharmaceutical industry with more efficient and faster tools. Thanks to the support of our investors, we will lead the market launch of the new assays CytoCHECK SPAchip® Detection kits for the analysis and monitoring of Calcium and pH change